Shanghai, China

Lefu Lan

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Chinese Academy of Sciences, East China University of Science and Technology. Active years: 2020-2021.


% Patents Active = 100.0


 

Average Co-Inventor Count = 7.2

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lefu Lan - Innovator in Antibacterial Drug Development

Introduction

Lefu Lan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial drugs. With a total of 2 patents, his work focuses on innovative compounds that address bacterial infections.

Latest Patents

Lefu Lan's latest patents include a class of vancomycin derivatives, which are designed to treat and prevent bacterial infections, especially those caused by Gram-positive bacteria. The patent details a preparation method, a pharmaceutical composition, and the use of these compounds in drug formulation. Another notable patent involves benzoheterocyclic alkylamine compounds, which serve as inhibitors of staphyloxanthin synthesis, contributing to the development of new antibacterial drugs.

Career Highlights

Throughout his career, Lefu Lan has worked with esteemed institutions such as the East China University of Science and Technology and the Chinese Academy of Sciences. His research has been pivotal in advancing the understanding and treatment of bacterial infections.

Collaborations

Lefu Lan has collaborated with notable colleagues, including Feifei Chen and Fei Mao, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Lefu Lan's innovative work in the field of antibacterial drug development showcases his commitment to addressing critical health challenges. His contributions through patents and collaborations continue to influence the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…